Search

Search Results
Results 4111 - 4120 of 5284 for Active site
  • Gynecologic cancer patients and advocates unite at FWC Forum in San Diego
    News - 15 Feb 2024
    The Foundation for Women's Cancer (FWC) is pleased to host a Patient and Advocate Education Forum on?? Friday, March 15, 2024, 10 a.m. – 4:30 p.m. PT, in San Diego, CA, at the San Diego Convention...
  • DBL Fluorouracil
    Drug - 9 Feb 2024
    Consumer Medicine Information (CMI) about DBL Fluorouracil intended for persons living in Australia.
  • Paxlovid enhances treatment options for COVID-19 patients
    News - 6 Feb 2024
    The design, synthesis, and mechanism of action of Paxlovid.
  • Atgam
    Drug - 30 Jan 2024
    Consumer Medicine Information (CMI) about Atgam intended for persons living in Australia.
  • Lucrin Depot and Lucrin Depot Paediatric PDS injection
    Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Lucrin Depot and Lucrin Depot Paediatric PDS injection intended for persons living in Australia.
  • Feiba-NF
    Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Feiba-NF intended for persons living in Australia.
  • Adynovate
    Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Adynovate intended for persons living in Australia.
  • IPOL
    Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about IPOL intended for persons living in Australia.
  • DBL Sodium Acetate Concentrated Injection
    Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about DBL Sodium Acetate Concentrated Injection intended for persons living in Australia.
  • Prevenar 20
    Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Prevenar 20 intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback